• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alopecia after injection of ATX-101 for reduction of submental fat.

作者信息

Souyoul Skylar, Gioe Olivia, Emerson Ashley, Hooper Deirdre O'Boyle

机构信息

Department of Dermatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana.

Louisiana State University School of Medicine, New Orleans, Louisiana.

出版信息

JAAD Case Rep. 2017 May 23;3(3):250-252. doi: 10.1016/j.jdcr.2017.02.021. eCollection 2017 May.

DOI:10.1016/j.jdcr.2017.02.021
PMID:28560296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5443891/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/344ce153baae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/6bea668334f1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/09bbea551e1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/344ce153baae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/6bea668334f1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/09bbea551e1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a457/5443891/344ce153baae/gr3.jpg

相似文献

1
Alopecia after injection of ATX-101 for reduction of submental fat.注射ATX-101以减少颏下脂肪后出现的脱发
JAAD Case Rep. 2017 May 23;3(3):250-252. doi: 10.1016/j.jdcr.2017.02.021. eCollection 2017 May.
2
The development, evidence, and current use of ATX-101 for the treatment of submental fat.ATX-101用于治疗颏下脂肪的研发、证据及当前应用情况。
J Cosmet Dermatol. 2017 Jun;16(2):174-179. doi: 10.1111/jocd.12347. Epub 2017 Apr 21.
3
Deoxycholic acid in the submental fat reduction: A review of properties, adverse effects, and complications.脱氧胆酸在颏下脂肪减少中的应用：性质、不良反应和并发症的综述。
J Cosmet Dermatol. 2020 Oct;19(10):2497-2504. doi: 10.1111/jocd.13619. Epub 2020 Jul 29.
4
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection.新型安全注射区用于减少颏下饱满度。
Plast Reconstr Surg. 2019 Dec;144(6):995e-1001e. doi: 10.1097/PRS.0000000000006299.
5
Deoxycholic Acid (ATX-101) for Reduction of Submental Fat.脱氧胆酸（ATX - 101）用于减少颏下脂肪。
Ann Pharmacother. 2016 Oct;50(10):855-61. doi: 10.1177/1060028016653966. Epub 2016 Jun 23.
6
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.ATX-101（脱氧胆酸注射液）概述：一种减少颏下脂肪的非手术方法。
Dermatol Surg. 2016 Nov;42 Suppl 1:S263-S270. doi: 10.1097/DSS.0000000000000870.
7
A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections.ATX-101的1期药代动力学研究：合成脱氧胆酸注射后的血清脂质和脂肪因子。
J Cosmet Dermatol. 2015 Mar;14(1):33-9. doi: 10.1111/jocd.12122. Epub 2015 Feb 14.
8
Noninvasive Submental Fat Compartment Treatment.无创颏下脂肪室治疗
Plast Reconstr Surg Glob Open. 2016 Dec 14;4(12 Suppl Anatomy and Safety in Cosmetic Medicine: Cosmetic Bootcamp):e1155. doi: 10.1097/GOX.0000000000001155. eCollection 2016 Dec.
9
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.ATX-101（脱氧胆酸注射液）治疗颏下脂肪减少患者体验的管理
Dermatol Surg. 2016 Nov;42 Suppl 1:S288-S299. doi: 10.1097/DSS.0000000000000908.
10
ATX-101 for reduction of submental fat.ATX-101用于减少颏下脂肪。
Expert Opin Pharmacother. 2015 Apr;16(5):755-62. doi: 10.1517/14656566.2015.1019465. Epub 2015 Feb 27.

引用本文的文献

1
Management of Serious Adverse Events Following Deoxycholic Acid Injection for Submental and Jowl Fat Reduction: A Systematic Review and Management Recommendations.去氧胆酸注射用于颏下和面颊部脂肪减少后的严重不良事件管理：一项系统评价与管理建议
Aesthet Surg J Open Forum. 2024 Aug 13;6:ojae061. doi: 10.1093/asjof/ojae061. eCollection 2024.
2
A novel approach for deoxycholic acid administration to treat submental fullness: A case report assessed by 3D stereophotogrammetry.一种用于治疗颏下丰满的新型脱氧胆酸给药方法：通过三维立体摄影测量法评估的病例报告。
J Oral Biol Craniofac Res. 2024 May-Jun;14(3):280-283. doi: 10.1016/j.jobcr.2024.03.011. Epub 2024 Mar 29.
3

本文引用的文献

1
Additional thoughts on the new treatment Kybella.关于新型治疗药物Kybella的更多思考。
Semin Cutan Med Surg. 2015 Sep;34(3):138-9. doi: 10.12788/j.sder.2015.0175.
2
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction.REFINE-1，一项多中心、随机、双盲、安慰剂对照的3期试验，使用ATX-101（一种用于减少颏下脂肪的注射药物）。
Dermatol Surg. 2016 Jan;42(1):38-49. doi: 10.1097/DSS.0000000000000578.
3
Deoxycholic acid (Kybella) for double chin.
Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment.
须部秃发：病因、表现及治疗的最新全面综述
J Clin Med. 2023 Jul 20;12(14):4793. doi: 10.3390/jcm12144793.
4
Chronic Infection and Nodule Formation following Deoxycholate Injection.脱氧胆酸盐注射后的慢性感染与结节形成
Arch Plast Surg. 2022 May 27;49(3):315-318. doi: 10.1055/s-0042-1748644. eCollection 2022 May.
5
Adverse effects of deoxycholic acid in submandibular glands, submental, inguinal and subplantar regions: a study in rats.脱氧胆酸对颌下腺、颏下、腹股沟和足底区域的不良反应：大鼠研究。
Clin Oral Investig. 2022 Mar;26(3):2575-2585. doi: 10.1007/s00784-021-04227-6. Epub 2022 Jan 28.
6
Real-World Experience With 100 Consecutive Patients Undergoing Neck Contouring With ATX-101 (Deoxycholic Acid): An Updated Report With A 2-Year Analysis.100例连续接受ATX-101（脱氧胆酸）颈部轮廓塑形患者的真实世界经验：一项2年分析的更新报告。
Dermatol Surg. 2019 Oct;45(10):1285-1293. doi: 10.1097/DSS.0000000000001811.
7
Evaluation of Safe and Effectiveness of an Injectable Solution Acid Deoxycholic Based for Reduction of Localized Adiposities.基于注射用酸脱氧胆酸溶液减少局部脂肪堆积的安全性和有效性评估。
Plast Reconstr Surg Glob Open. 2018 Jun 11;6(6):e1794. doi: 10.1097/GOX.0000000000001794. eCollection 2018 Jun.
Med Lett Drugs Ther. 2015 Dec 7;57(1483):165-6.
4
Safety and efficacy of cryolipolysis for non-invasive reduction of submental fat.冷冻溶脂术用于无创减少颏下脂肪的安全性和有效性。
Lasers Surg Med. 2016 Jan;48(1):3-13. doi: 10.1002/lsm.22440. Epub 2015 Nov 26.
5
Pharmaceutical Approval Update.药品审批更新
P T. 2015 Jul;40(7):427-9.
6
What Does the Data from the ATX-101 Phase I Safety and Pharmacokinetic Study Tell Us?ATX - 101一期安全性和药代动力学研究的数据告诉了我们什么？
J Drugs Dermatol. 2015 Jun;14(6):544-5.
7
A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections.ATX-101的1期药代动力学研究：合成脱氧胆酸注射后的血清脂质和脂肪因子。
J Cosmet Dermatol. 2015 Mar;14(1):33-9. doi: 10.1111/jocd.12122. Epub 2015 Feb 14.
8
Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.对两项欧洲的、随机的、安慰剂对照的3期研究进行汇总分析的结果，这些研究是关于ATX-101用于药物性减少颏下多余脂肪的。
Aesthetic Plast Surg. 2014 Oct;38(5):849-60. doi: 10.1007/s00266-014-0364-9. Epub 2014 Jul 2.
9
Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.ATX-101（脱氧胆酸），一种用于减少颏下多余脂肪的注射药物的疗效、患者报告结局及安全性概况：一项III期随机安慰剂对照研究的结果
J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1707-15. doi: 10.1111/jdv.12377. Epub 2014 Mar 8.
10
Dissolving unwanted submental fat.
Br J Dermatol. 2014 Feb;170(2):237-8. doi: 10.1111/bjd.12762.